The FDA has granted Fast Track designation to 2 investigational combination vaccines to prevent influenza and COVID-19 infections in adults 50 years and older.

The ACIP recommendations have been updated for the meningococcal serogroup B MenB-4C vaccine (Bexsero), in accordance with the updated US FDA label.

Higher ambient levels of air pollutants are associated with increased risk for venous thromboembolism, according to study findings.

Patients who received the original monovalent mRNA COVID-19 vaccine were less likely than unvaccinated patients to be hospitalized for COVID-19-associated VTE.

Beans, peas and lentils take center stage in newly proposed changes to dietary guidelines for Americans. The updated guidelines take into account numerous published studies on long-term links between ...

Only 37% of children had received the influenza vaccine as of November 30th, down from 43% at the same time last year.

Geriatric care for LGBTQ+ adults who live in rural communities requires cultural competence training and diverse health care teams.

In September 2024, the Food and Drug Administration (FDA) approved a label update for Heplisav-B (hepatitis B vaccine [recombinant], adjuvanted) that included data from a post-licensure, observational ...

The burden of respiratory syncytial virus in young children continues to be high in the United States, according to study findings.

Increased rates of congenital syphilis in the United States and continuum may be due to systemic barriers to comprehensive care and treatment.

More recent birth cohorts have lower levels of total cholesterol and fasting triglyceride levels, and higher levels of fasting glucose.

A third dose of COVID-19 vaccine is beneficial among older Medicare beneficiaries, regardless of prior medically attended COVID-19 diagnoses.